TRIB3 and neoplasm: Although specific TRIB3 inhibitors are not yet available, recent studies have identified several compounds with TRIB3 inhibitory properties, including hesperidin.[44] In line with our findings, these compounds demonstrated ability to inhibit tumor progression by inducing ferroptosis in preclinical models.